Provided by Tiger Trade Technology Pte. Ltd.

GENSCRIPT BIO

34.440
+1.0803.24%
Volume:34.78M
Turnover:1.19B
Market Cap:75.70B
PE:-17.87
High:34.760
Open:33.200
Low:32.500
Close:33.360
52wk High:35.220
52wk Low:10.360
Shares:2.20B
HK Float Shares:2.20B
Volume Ratio:0.51
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.927
ROE:-15.33%
ROA:1.54%
PB:2.48
PE(LYR):-17.87
PS:11.43

Loading ...

BUZZ-Genscript hits 4-week high on associate's promising blood cancer cell therapy

Reuters
·
Jun 03

Movement Alert|GenScript Biotech Rises 23.48% in Regular Trading, Legend Biotech In Vivo CAR-T Clinical Data Shows Positive Signals

Market Focus
·
Jun 03

Stock Track | GENSCRIPT BIO Soars 14.99% Intraday on Positive Clinical Data from Associate Legend Biotech

Stock Track
·
Jun 03

Genscript Biotech Soars on Positive Clinical Data from Affiliate Legend Biotech

Stock News
·
Jun 03

Key Developments for Hong Kong Stocks: Gold Surpasses U.S. Bonds as Top Reserve Asset; NVIDIA's Spectrum-X Ethernet Silicon Photonics Tech Enters Full Production

Stock News
·
Jun 03

GenScript Biotech’s Associate Legend Biotech Schedules Late-Breaking Oral at EHA 2026 to Reveal Initial Phase 1 In Vivo CAR-T Data for LB2501 in R/R B-NHL

Bulletin Express
·
Jun 02

GenScript says Legend to present Phase 1 in vivo CAR-T LB2501 data at EHA congress

Reuters
·
Jun 02

GENSCRIPT BIO discloses Legend Biotech’s first-in-human LB2102 CAR-T results and new CARVYKTI® data presented at ASCO 2026

Bulletin Express
·
Jun 01

Genscript Biotech Reports LB2102 Solid Tumor Initial Human Study Results and CARVYKTI® Latest Data in Myeloma at 2026 ASCO

Stock News
·
Jun 01

Stock Track | GENSCRIPT BIO Plummets 5.26% Intraday on Post-ASCO Profit-Taking and Sector Weakness

Stock Track
·
Jun 01

Movement Alert|GenScript Biotech Falls 5.19% in Regular Trading, Post-ASCO Profit-Taking Continues Amid Sector Weakness

Market Focus
·
Jun 01

J&J Mastered Cancer Biotech Deals on the Cheap. Can it Stay on the Cutting Edge? -- Heard on the Street -- WSJ

Dow Jones
·
May 28

Stock Track | GENSCRIPT BIO Plummets 5.54% Intraday on Profit-Taking After ASCO Rally and Sector Weakness

Stock Track
·
May 28

Movement Alert|GenScript Biotech Falls 5.01% in Regular Trading, Profit-Taking After ASCO Catalyst Combines with Sector Weakness

Market Focus
·
May 28

GENSCRIPT BIO Surges Over 5% Following Partner Legend Biotech's ASCO 2026 Research Presentations

Stock News
·
May 27

Stock Track | GenScript Bio Soars 5.57% Intraday on ASCO Data Releases and Valuation Sentiment

Stock Track
·
May 27

Movement Alert|GenScript Biotech Rises 5.12% in Regular Trading, Legend Biotech ASCO Data Releases Boost Sentiment

Market Focus
·
May 27

Genscript Biotech (01548): Legend Biotech Unveils Multiple Research Findings at 2026 ASCO Annual Meeting

Stock News
·
May 22

Stock Track | GENSCRIPT BIO Soars 5.45% Intraday on Sector Optimism and Strong Associate Performance

Stock Track
·
May 13

GENSCRIPT BIO Surges Over 5% as Associate Legend Biotech Reports Narrowed Loss and Strong CARVYKTI® Sales Growth

Stock News
·
May 13